Register for the upcoming 2027 Change Provider Trainings

Join our Provider Relations team members for the virtual provider collaboration session(s). Register Now

Show More

Wegovy Injectable Coverage Expands for MASH Diagnosis

Blue Cross Blue Shield of North Dakota (BCBSND) covers Wegovy injectable for members diagnosed with Metabolic dysfunction-associated steatohepatitis (MASH), formerly known as Non-Alcoholic Steatohepatitis (NASH). This coverage is available to all commercial members who meet prior authorization (PA) requirements despite their plan’s specific weight loss benefits.

A new PA for the MASH diagnosis may be required for members whose weight loss benefits changed in 2026. For details on coverage and PA requirements, visit MyPrime.com.